[1]
W. Widowati, “In Silico Approach for Pro-inflammatory Protein Interleukin 1β and Interleukin-1 Receptor Antagonist Protein Docking as Potential Therapy for COVID-19 Disease”, Open Access Maced J Med Sci, vol. 10, no. A, pp. 65–70, Jan. 2022.